{"transactions":[{"id":1676642,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":95084,"kind":"person","name":"van Dijk Marcus Antonius","position":1,"cik":"0001881659","reported_name":"van Dijk Marcus Antonius","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option","published_at":"2024-01-18T20:00:08.000Z","date":"2024-01-16","kind":"grant","planned":false,"acquired":true,"shares":171078,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"An option to purchase Common Stock was granted to Dr. van Dijk on January 16, 2024 for his performance in 2023, and awarded in accordance with the MiNK Therapeutics, Inc. 2021 Equity Incentive Plan. Half of the options will vest on June 27, 2024 and half of the options will vest on September 27, 2024."}],"balance_after":171078,"derivative":{"exercise_price":0.87,"expiration_date":"2034-01-16","underlying":"Common Stock","underlying_shares":171078},"source":{"system":"sec-edgar","filing":"0000950170-24-005561","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1881659/000095017024005561/ownership.xml","form_type":"4"}},{"id":1676641,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":95084,"kind":"person","name":"van Dijk Marcus Antonius","position":1,"cik":"0001881659","reported_name":"van Dijk Marcus Antonius","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option","published_at":"2024-01-18T20:00:08.000Z","date":"2024-01-16","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"An option to purchase Common Stock was granted to Dr. van Dijk on January 16, 2024 and awarded in accordance with the MiNK Therapeutics, Inc. 2021 Equity Incentive Plan. The option vests over a three-year period, with one-third of the options vesting on the one-year anniversary of the grant date, with the remainder vesting in equal quarterly installments thereafter."}],"balance_after":15000,"derivative":{"exercise_price":0.87,"expiration_date":"2034-01-16","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000950170-24-005561","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1881659/000095017024005561/ownership.xml","form_type":"4"}},{"id":2055763,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":95084,"kind":"person","name":"van Dijk Marcus Antonius","position":1,"cik":"0001881659","reported_name":"van Dijk Marcus Antonius","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-01-12T10:48:51.000Z","date":"2023-01-09","kind":"tax_withholding","acquired":false,"shares":24265,"price":2.32,"value":56294.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents payment of tax liability by withholding shares of common stock incident to the vesting of stock."}],"balance_after":27363,"source":{"system":"sec-edgar","filing":"0000899243-23-001660","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1881659/000089924323001660/doc4.xml","form_type":"4"}},{"id":2055762,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":95084,"kind":"person","name":"van Dijk Marcus Antonius","position":1,"cik":"0001881659","reported_name":"van Dijk Marcus Antonius","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-01-12T10:48:51.000Z","date":"2023-01-09","kind":"grant","acquired":true,"shares":51628,"price":2.32,"value":119776.96,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects the executive's 2022 performance bonus award paid in MiNK Therapeutics, Inc. common stock. The stock issued is fully-vested on the date of issuance but is subject to a lockup restriction with 50% of the award released on March 24, 2023 and 50% of the award released on June 24, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"$2.32 was the fair market value of MiNK Therapeutics, Inc. Common Stock on January 9, 2023, the stock issuance date."}],"balance_after":51628,"source":{"system":"sec-edgar","filing":"0000899243-23-001660","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1881659/000089924323001660/doc4.xml","form_type":"4"}},{"id":2056623,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":95084,"kind":"person","name":"van Dijk Marcus Antonius","position":1,"cik":"0001881659","reported_name":"van Dijk Marcus Antonius","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option","published_at":"2023-01-11T17:26:37.000Z","date":"2023-01-09","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option was granted on January 9, 2023 and awarded in accordance with the MiNK Therapeutics, Inc. 2021 Equity Incentive Plan. Option vests over a three-year period, with one-third of the options vesting on the one-year anniversary of the grant date, with the remainder vesting in equal quarterly installments thereafter."}],"balance_after":15000,"derivative":{"exercise_price":2.32,"expiration_date":"2033-01-09","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-23-001622","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1881659/000089924323001622/doc4.xml","form_type":"4"}},{"id":2426902,"issuer":{"id":52,"kind":"organization","name":"MiNK Therapeutics, Inc.","symbol":"INKT"},"owners":[{"id":95084,"kind":"person","name":"van Dijk Marcus Antonius","position":1,"cik":"0001881659","reported_name":"van Dijk Marcus Antonius","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-25T17:19:36.000Z","date":"2022-01-21","kind":"grant","acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an option to purchase shares of the common stock, which vests as to 35% of the underlying shares on January 21, 2025 and as to the remaining 65% of the underlying shares on January 21, 2026; provided that the Reporting Person maintains a business relationship with the Issuer through each such vesting date."}],"balance_after":62500,"derivative":{"exercise_price":3.12,"expiration_date":"2032-01-21","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0000899243-22-003171","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1881659/000089924322003171/doc4.xml","form_type":"4"}}]}